Testosterone testing before treatment is the step most men skip and most programs skip for them, because a prescription without measurement is faster to sell. The honest sequence runs the other way. Symptoms are the complaint, the panel is the evidence and therapy is a decision made where the two agree, monitored on a schedule afterward. This guide walks through what a real testosterone workup measures, why each marker is on the list and what separates a clinician who prescribes from labs from one who prescribes from a form.
- Total testosterone alone is not a diagnosis and a single low reading on one morning is not a panel.
- Free testosterone and SHBG explain symptoms that a normal total reading hides.
- LH and FSH locate the problem, whether the signal from the brain or the response of the testes.
- Baseline blood counts, lipids, metabolic and prostate markers are read before therapy, not after.
- Therapy, where indicated, is titrated against quarterly labs and a flat $299 monthly fee that never rises with the dose.
Why measurement comes first
The symptoms of low testosterone are real and they are also shared with half a dozen other conditions. Fatigue, low libido, brain fog, changed motivation and reduced strength all have common alternative explanations, thyroid dysfunction, sleep apnea, depression, medication effects and insulin resistance among them. A panel that skips measurement treats the symptom without ever confirming the cause, which is why therapy started without labs so often disappoints.
The Endocrine Society's clinical guidance on testosterone therapy frames diagnosis as a two-part test, symptoms plus clearly low levels confirmed on more than one morning draw and the guidance is deliberately conservative because testosterone is a controlled substance with real cardiovascular and hematologic considerations. A program that cannot name its diagnostic standard is telling you something about the prescribing to come.
What the panel actually reads
Total testosterone. The headline number, drawn in the morning when levels peak and confirmed on a second draw before any diagnosis. A single afternoon reading in the low-normal band proves nothing in either direction.
Free testosterone. The fraction available to tissue and the number that explains symptoms when total looks acceptable. It requires either a reliable assay or a calculation from total and SHBG, which is why SHBG sits on the list.
SHBG. The binding protein that controls how much of the total is actually free. High SHBG lowers free T even when total reads normal, which is one of the most common misreadings in this lane.
LH and FSH. The brain's signal to the testes. Low LH with low testosterone points toward a secondary cause and high LH points toward primary testicular failure. Locating the problem changes what the treatment conversation looks like.
Baseline blood counts. Hemoglobin and hematocrit rise on testosterone therapy and have to be watched, which makes the pre-treatment baseline non-negotiable rather than optional.
Lipids, metabolic and prostate markers. ApoB, HbA1c, insulin markers and PSA are read before therapy because testosterone does not act in isolation from the cardiovascular and metabolic systems it interacts with.
What each marker answers before therapy
| Marker | What it answers | Why it matters |
|---|---|---|
| Total testosterone (morning, twice) | Is the level clearly low | Confirms the diagnosis exists |
| Free testosterone | Is the available fraction low | Explains symptoms with normal total |
| SHBG | How much total is free | Prevents the most common misread |
| LH and FSH | Where the problem sits | Separates primary from secondary causes |
| Hematocrit baseline | Where blood counts start | Therapy raises them and they are watched |
| ApoB, HbA1c, PSA | What else the system is doing | Therapy is prescribed against the whole picture |
The morning draw and why timing matters
Testosterone follows a daily rhythm and peaks in the morning, which makes the timing of the draw part of the measurement rather than a detail. An afternoon draw can read a healthy man as low and a genuinely low man as borderline. The clinical standard is a morning draw confirmed by a second one and both are read against age-appropriate ranges rather than the broad population range the lab report prints.
This is the practical difference between a program that measures and one that does not. The one that does not will accept any reading at any hour and treat the number it gets, which is how men end up on therapy they never needed or off therapy they did.
What was my free testosterone and my SHBG and what did my baseline blood counts show? A program that cannot answer is prescribing from a single number.


What happens after the panel
When the panel confirms measured deficiency and the symptoms agree, therapy is a legitimate clinical decision and the monitoring question becomes the next one that matters. Testosterone therapy titrates against quarterly labs, blood counts, lipids and hormone levels among them, toward the lowest dose that holds the level in range and the symptoms resolved. A program without a monitoring cadence is prescribing blind and a program whose fee rises with the dose has a structural reason to prescribe high.
Our structure removes both problems. The quarterly Biomarker Audit repeats the full panel every 90 days inside the flat fee and the membership is one flat $299 a month for the clinical relationship and four audits a year, with a two month commitment at the start paid as a single $598 charge covering the first two months together. Medication is a separate charge billed by the pharmacy at its own price with zero markup and no dose escalation fee on our side. We make money when you get healthier, not when your dose gets stronger.
Where the panel does not confirm deficiency, the honest answer is that therapy is not supported and the panel usually reveals what actually needs attention instead, thyroid, sleep, insulin resistance or the estrogen picture.
What the panel misses, honestly
Credibility requires the other direction too, because a trust asset that only lists what testing catches is a brochure. The testosterone panel has real blind spots and pretending otherwise is how men get overdiagnosed as often as underdiagnosed.
Testosterone fluctuates with sleep, illness, stress and training load, so a low reading during a bad month can be a snapshot of a bad month rather than of a deficiency, which is why the confirmation draw matters and why the panel is read in context rather than in isolation. The symptoms overlap with conditions the panel does not measure, depression and sleep apnea chief among them and a clinician who never screens for either is mislabeling men as hypogonadal when the driver sits elsewhere. Reference ranges themselves are debated, with some societies arguing for age-adjusted thresholds and others for lower population cutoffs, so the same blood can produce two different labels at two different clinics.
What this means practically is that the panel is necessary and not sufficient. It rules the metabolic and hormonal picture in or out and it monitors therapy honestly once started, but the reading requires a clinician who takes the history seriously and the history is where the symptoms either fit the labs or do not. Any program that skips the history and treats the number has the same failure mode as one that skips the number and treats the complaint.
Clinical care is delivered by physicians of Beluga Health, P.A., an independent Florida professional corporation licensed in all 50 states, working under GoodLife Health's clinical protocols. All labs run through the Beluga Health lab network.
FAQ
What labs are checked before testosterone therapy? A morning total testosterone confirmed on a second draw, free testosterone, SHBG, LH and FSH, a baseline blood count and the metabolic and cardiovascular markers including ApoB and HbA1c, with prostate screening per your clinician's judgment.
Can total testosterone be normal while symptoms persist? Yes and it is one of the most common patterns. High SHBG can hold total in range while the free fraction available to tissue runs low, which is why free testosterone and SHBG are read alongside the total.
Why does the draw have to be in the morning? Testosterone peaks in the morning and an afternoon draw can misread a healthy man as low. The clinical standard is a morning draw confirmed by a second one.
Is low testosterone always treated with therapy? No. Where the panel does not confirm deficiency the therapy is not supported and the honest program reads the panel for what actually needs attention, thyroid, sleep, insulin resistance or something else.
How is testosterone therapy monitored? Against quarterly labs, blood counts, lipids and hormone levels among them, titrated toward the lowest dose that holds the level in range and the symptoms resolved.
Does the GoodLife Health fee change with the testosterone dose? No. The fee is a flat $299 a month at any dose, with a two month commitment at the start paid as a single $598 charge. Medication is billed by the pharmacy at its own price separately.
Related Guides
- Hormone optimization: the complete guide
- Are online TRT clinics legit
- What a Biomarker Audit includes
- Hormone optimization at GoodLife Health
References
- Endocrine Society clinical guidance on testosterone therapy. 2026. www.endocrine.org/clinical-practice-guidelines